Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nutrition Journal|October 17, 2022
Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trialSamantha Galluzzi, Roberta Zanardini, Clarissa Ferrari, et al.
Cells|February 15, 2022
Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer's Disease and Dementia with Lewy BodiesAntonio Longobardi, Roland Nicsanu, Sonia Bellini, et al.
Journal of Personalized Medicine|August 29, 2024
Cognitive, Neuropsychological and Biological Effects of Oxygen-Ozone Therapy on Frailty: A Study Protocol for a 5-Week, Randomized, Placebo-Controlled TrialCatia Scassellati, Cristian Bonvicini, Miriam Ciani, et al.
Journal of Alzheimer'S Disease : JAD|March 11, 2022
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's DiseaseRoland Nicsanu, Carlo Cervellati, Luisa Benussi, et al.
International Journal of Molecular Sciences|February 27, 2026
Exploration of Early-Treatment-Associated Changes in Metabolic and Inflammatory Biomarkers in First-Episode Psychosis in Italian PatientsElisabetta Maffioletti, Clarissa Ferrari, Roberta Zanardini, et al.
Cells|June 14, 2020
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's DiseaseMaria Serpente, Chiara Fenoglio, Marianna D'Anca, et al.
Psychoneuroendocrinology|December 22, 2019
Childhood trauma and glucose metabolism in patients with first-episode psychosisSarah Tosato, Chiara Bonetto, Simona Tomassi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2022
Serum neurofilament light in professional soccer players: goal on safetyClaudio Cornali, Paolo Amaddeo, Alberto Benussi, et al.
Brain, Behavior, and Immunity|March 18, 2018
Immune and metabolic alterations in first episode psychosis (FEP) patientsLuisella Bocchio-Chiavetto, Roberta Zanardini, Sarah Tosato, et al.
International Journal of Molecular Sciences|December 24, 2021
Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer's Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease GeneLuisa Benussi, Antonio Longobardi, Cemile Kocoglu, et al.
Pageof 5